Clinical Trial Update: Ceritinib and Everolimus in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIB-IV Non-small Cell Lung Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial update for ceritinib and everolimus in patients with locally advanced or metastatic solid tumors, including non-small cell lung cancer. The study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Ceritinib (ceritinib)
• Everolimus (everolimus)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: ALK Positive, Locally Advanced Malignant Solid Neoplasm | Phase 1 | Status: ACTIVE_NOT_RECRUITING